CCCC vs SNA · rev $35.6M vs P/E 17, rev $5.11B
C4 Therapeutics Inc (CCCC) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported SNA revenue for 2024-12-28 was $5.11B. Net income was $1.07B. Revenue was up 0.0% from 2023-12-30 to 2024-12-28. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
CCCC currently screens at market cap $425.7M. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the CCCC and SNA stock pages for the full models.
Not investment advice.